Both are still in trials but 10 months with chemotherapy versus 2.4 months could bring the drug to the front view of the public, as has been done in the past with activists groups pushing for approval of other drugs. Both are different with treatment plans and the drugs would be limited to the...
Posted to
The Medical Quack .... by Barbara Duck
on 12-04-2008
Filed under: Medically Related, Pharma/FDA News, healthcare, Pharma, Cancer, clinical trials, Prostate Cancer, PSA, R and D, antigen, testosterone
According to the study, statins are lowering the PSA levels, but the concern is whether or not this could be hiding or clouding the issues and cancer could be potentially missed in the diagnosis as they are not sure if this is lowering the test numbers or if it is in fact helping in the prevention of...
Physicians can now implant seeds to any and every region of the gland and the device is finding cancer cells that previously were previously undetected, yet blood test were showing cancer cells were present. Video at the link below. If this can locate and find cancer cells that were previously...
Posted to
The Medical Quack .... by Barbara Duck
on 10-28-2008
Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Medical Devices, Prostate Cancer, Diagnosis, TargetScan Touch
Not available here in the US yet, but this is a genomic based test that is cancer specific. Nobody likes having a biopsy done by any means and this appears to be working in that direction, in other words more information available to perhaps avoid biopsies that are perhaps not required. BD...
The tool is designed for use by doctors and will still need to go through clinical trials to determine accuracy and effectiveness. This is a joint effort and will be tested at Harvard Medical School and the Cleveland Clinic. Radiation oncologists and urologists are the targeted physicians...
Posted to
The Medical Quack .... by Barbara Duck
on 09-24-2008
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, Cancer, Oncology, Prostate Cancer, PSA, Online Tools, Biopsy, Calculator
Additional information is available at the website along with a listing of the peer committee. Over $350 million has been raised by the foundation. In addition to the Young Investigators awards the Challenge Awards were also recently in the news and announced. Online donations and subscriptions...
Posted to
The Medical Quack .... by Barbara Duck
on 08-19-2008
Filed under: Medically Related, Pharma/FDA News, cancer research, Research, Oncology, Prostate Cancer, PCF, Pathology, Prostate Cancer Foundation, Radiation Oncology, Healthcare Awards, Imaging Science, Molecular Science
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
on 08-07-2008
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test